Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Costanza, Mariantonia Dr. (1) Diecke, Sebastian Dr. (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Kastelic, Nicolai (1) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (2) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (1) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (15) Pezzutto, Antonio Prof. Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (2) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (18) Uyar, Bora Dr. (1) Willnow, Thomas Prof. Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (3) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (12) (-) Biologie maligner Lymphome (12) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immundysregulationen in der Onkologie (1) Immunregulation und Krebs (1) Molekulare Immunologie und Gentherapie (35) Proteomics (1) Psychoneuroimmunologie (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (3) Translationale Onkologie solider Tumore (2) Translationale Tumorimmunologie (1) Zelluläre Neurowissenschaften (1) 1999 (1) 2000 (1) 2002 (1) 2003 (3) (-) 2004 (2) (-) 2005 (2) (-) 2006 (4) (-) 2007 (2) 2008 (2) 2009 (3) (-) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (2) 2015 (2) 2016 (1) 2017 (3) (-) 2018 (1) 2020 (4) 2021 (5) 2022 (4) 2023 (6) 2024 (1) 12 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Biologie maligner Lymphome200420052006200720102018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas 01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou 01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas 01. Mai 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 19. April 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken 01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch 25. August 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou
01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
01. Mai 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
19. April 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken
01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
25. August 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel